Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

This Penny Stock Cardiac-Drug Maker Is Gaining Momentum: Could the Next Move Be Even Bigger?

ThisPenny Stockcardiac-drug maker, Milestone Pharmaceuticals (NASDAQ:MIST), is a commercial-stage biopharmaceutical company whose lead product, etripamil, branded CARDAMYST, is a self-administered nasal-spray treatment for paroxysmal supraventricular tachycardia, or PSVT, a type of rapid heart rhythm. Shares closed at $1.20 at last closing, down 0.83%.

Nitish Kishor | 08 September 2026

HealthStream (NASDAQ:HSTM) Stock Slides: Is It Coiling for a Breakout Anyway?

HealthStream (NASDAQ:HSTM) is a healthcare-technology company that provides workforce-focused software-as-a-service, including learning, credentialing, competency, and scheduling solutions for hospitals and health systems. Shares closed at $29.20 at last closing, down 1.82%.

Nitish Kishor | 08 September 2026

Penny Stock Lineage Cell Therapeutics (NYSE American:LCTX) Stock Slips: What Should Investors Watch Next?

Penny stock Lineage Cell Therapeutics (NYSE American:LCTX) is a clinical-stage biotechnology company developing allogeneic, or off-the-shelf, cell therapies, with its lead program, OpRegen, partnered with Roche and its Genentech unit for geographic atrophy secondary to age-related macular degeneration. Shares closed at $1.08 at last …

Nitish Kishor | 08 September 2026

Gyre Therapeutics (NASDAQ:GYRE) Stock Jumps: Could the Next Catalyst Change Everything?

Gyre Therapeutics (NASDAQ:GYRE) is a biopharmaceutical company created through aReverse mergerwith the former Catalyst Biosciences, whose operations are centered on its China-based subsidiary, giving it substantial commercial product revenue unusual for a US-listed biopharma. Shares closed at $6.86 at last closing, up 6.52%.

Nitish Kishor | 08 September 2026

Creative Medical Technology Holdings (NASDAQ:CELZ) Stock Jumps: What Could Reverse the Rough Patch?

Penny stock Creative Medical Technology Holdings (NASDAQ:CELZ) is a clinical-stage regenerative-medicine and biotechnology company developing stem-cell and immunotherapy candidates across areas such as type 1 diabetes and orthopedics. Shares closed at $1.11 at last closing, up 4.72%.

Nitish Kishor | 08 September 2026

Penny Stock Autonomix Medical (NASDAQ:AMIX) Stock Gets Hit Hard: Overdone or Just Getting Started?

Penny stock Autonomix Medical (NASDAQ:AMIX) is a pre-revenue, clinical-stage medical-device micro-cap developing a catheter-based sensing-and-ablation technology that aims to detect and treat peripheral nerve signals, with a lead program targeting pain from pancreatic and other visceral cancers. Shares closed at $4.59 at last closing, …

Nitish Kishor | 08 September 2026

Penny Stock Seer (NASDAQ:SEER) Stock: What Could Reverse the Momentum?

Penny stock Seer (NASDAQ:SEER) is a life-sciences company that has developed a proteomics platform, its Proteograph product, which uses nanoparticle technology to enable large-scale study of proteins. Shares traded at $1.95 in today's intraday trading, up 0.52%.

Nitish Kishor | 04 September 2026

This Penny Stock Health-Tech Name Ticked Higher Today: Opportunity or More Risk?

This penny stock, Spectral AI (NASDAQ:MDAI), is a medical-technology company developing artificial-intelligence-based predictive diagnostics, with its lead technology, DeepView, designed to help clinicians assess the severity of burns and wounds. Shares traded at $1.57 in today's intraday trading, up 0.64%.

Nitish Kishor | 04 September 2026

This Biopharma Stock Is Quiet Today: Is It Coiling for a Breakout?

This biopharma stock, Insmed (NASDAQ:INSM), is a biopharmaceutical company focused on serious and rare diseases, with its established product Arikayce for a rare lung infection and a newly launched product for bronchiectasis. Shares traded at $126.89 in today's intraday trading, up 0.16%.

Nitish Kishor | 04 September 2026

This Rehabilitation-Hospital Stock Has Gone Quiet: Is a Surprise Move Building?

This rehabilitation-hospital stock, Encompass Health (NYSE:EHC), is the largest owner and operator of inpatient rehabilitation hospitals in the United States, providing post-acute rehabilitation care to patients recovering from conditions such as strokes, injuries, and major surgeries. Shares traded at $122.60 in today's intraday trading, …

Nitish Kishor | 04 September 2026
Support

Hi! How can we help you today?

Loading…